These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 8978707

  • 1. L-deprenyl protects mesencephalic dopamine neurons from glutamate receptor-mediated toxicity in vitro.
    Mytilineou C, Radcliffe P, Leonardi EK, Werner P, Olanow CW.
    J Neurochem; 1997 Jan; 68(1):33-9. PubMed ID: 8978707
    [Abstract] [Full Text] [Related]

  • 2. L-(-)-desmethylselegiline, a metabolite of selegiline [L-(-)-deprenyl], protects mesencephalic dopamine neurons from excitotoxicity in vitro.
    Mytilineou C, Radcliffe PM, Olanow CW.
    J Neurochem; 1997 Jan; 68(1):434-6. PubMed ID: 8978757
    [Abstract] [Full Text] [Related]

  • 3. Deprenyl rescues dopaminergic neurons in organotypic slice cultures of neonatal rat mesencephalon from N-methyl-D-aspartate toxicity.
    Shimazu S, Katsuki H, Akaike A.
    Eur J Pharmacol; 1999 Jul 14; 377(1):29-34. PubMed ID: 10448922
    [Abstract] [Full Text] [Related]

  • 4. L-deprenyl fails to protect mesencephalic dopamine neurons and PC12 cells from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion.
    Vaglini F, Pardini C, Cavalletti M, Maggio R, Corsini GU.
    Brain Res; 1996 Nov 25; 741(1-2):68-74. PubMed ID: 9001706
    [Abstract] [Full Text] [Related]

  • 5. Deprenyl and desmethylselegiline protect mesencephalic neurons from toxicity induced by glutathione depletion.
    Mytilineou C, Leonardi EK, Radcliffe P, Heinonen EH, Han SK, Werner P, Cohen G, Olanow CW.
    J Pharmacol Exp Ther; 1998 Feb 25; 284(2):700-6. PubMed ID: 9454817
    [Abstract] [Full Text] [Related]

  • 6. L-deprenyl (selegiline) decreases excitatory synaptic transmission in the rat hippocampus via a dopaminergic mechanism.
    Hsu KS, Huang CC, Su MT, Tsai JJ.
    J Pharmacol Exp Ther; 1996 Nov 25; 279(2):740-7. PubMed ID: 8930179
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of MAO-B inhibitors on MPP+ toxicity in Vivo.
    Wu RM, Chen RC, Chiueh CC.
    Ann N Y Acad Sci; 2000 Nov 25; 899():255-61. PubMed ID: 10863544
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Increased survival of dopaminergic neurons by rasagiline, a monoamine oxidase B inhibitor.
    Finberg JP, Takeshima T, Johnston JM, Commissiong JW.
    Neuroreport; 1998 Mar 09; 9(4):703-7. PubMed ID: 9559942
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Neurotoxicity of polyamines and pharmacological neuroprotection in cultures of rat cerebellar granule cells.
    Sparapani M, Dall'Olio R, Gandolfi O, Ciani E, Contestabile A.
    Exp Neurol; 1997 Nov 09; 148(1):157-66. PubMed ID: 9398458
    [Abstract] [Full Text] [Related]

  • 16. [A comparison of the pharmacology of (-)-deprenyl to N-methylpropargylamine-1-aminoindane (J-508) and rasagiline, the desmethyl-analogue of J-508].
    Miklya I.
    Neuropsychopharmacol Hung; 2008 Mar 09; 10(1):15-22. PubMed ID: 18771016
    [Abstract] [Full Text] [Related]

  • 17. N-propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl.
    Karoum F.
    Br J Pharmacol; 1987 Feb 09; 90(2):335-45. PubMed ID: 3103805
    [Abstract] [Full Text] [Related]

  • 18. R(-)-deprenyl potentiates dopamine-induced cytotoxicity toward catecholaminergic neuroblastoma SH-SY5Y cells.
    Lai CT, Yu PH.
    Toxicol Appl Pharmacol; 1997 Jan 09; 142(1):186-91. PubMed ID: 9007048
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.